Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -34,030 | -107,633 | -62,717 | -46,111 | -24,414 |
| Depreciation Amortization | 13,185 | 11,218 | 8,487 | 45 | 198 |
| Accounts receivable | -3,291 | N/A | N/A | N/A | -311 |
| Accounts payable and accrued liabilities | 1,336 | 275 | 577 | 3,171 | 263 |
| Other Working Capital | -9,681 | -4,656 | -10,273 | 2,126 | -2,192 |
| Other Operating Activity | -75,078 | -233 | 11,007 | 13,967 | -1,110 |
| Operating Cash Flow | $-107,559 | $-101,029 | $-52,919 | $-26,802 | $-27,566 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -465 | -78 | -540 | -47 | 4,310 |
| Other Investing Activity | 103,387 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $102,922 | $-78 | $-540 | $-47 | $4,310 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 9,487 | N/A | N/A | N/A |
| Debt Repayment | N/A | N/A | N/A | N/A | -3,055 |
| Common Stock Issued | 2,989 | 196,039 | 23,504 | 94,150 | 48,508 |
| Common Stock Repurchased | -230 | 0 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 14,750 | 0 | 45,032 | 385 |
| Financing Cash Flow | $2,759 | $220,276 | $23,504 | $139,182 | $45,838 |
| Exchange Rate Effect | -1,287 | 260 | -2,087 | -1,679 | 718 |
| Beginning Cash Position | 251,272 | 131,843 | 163,885 | 53,231 | 29,931 |
| End Cash Position | 248,107 | 251,272 | 131,843 | 163,885 | 53,231 |
| Net Cash Flow | $-3,165 | $119,429 | $-32,042 | $110,654 | $23,300 |
| Free Cash Flow | |||||
| Operating Cash Flow | -107,559 | -101,029 | -52,919 | -26,802 | -27,566 |
| Capital Expenditure | -465 | -78 | -540 | -61 | -190 |
| Free Cash Flow | -108,024 | -101,107 | -53,459 | -26,863 | -27,756 |